(Total Views: 589)
Posted On: 06/03/2022 2:27:27 PM
Post# of 154883
Novavax and CytoDyn started their covid trials at the same time in May 2020. Still no EUA for Novavax, I don't own NVAX but I use it as a canary in the mine shaft. Today Novavax was again attacked by the FDA; the FDA suggested today there could be a link between Novavax's Covid vaccine and heart inflammation, and NVAX stock plummeted. This vaccine has approval in several other countries. "This interim
allows their competing drugs to flourish while others die" is exactly right.
NVAX suffered the exact same fake law suits we did, same firms, etc. Ours have now gone away because we are no longer a threat.
Will be interesting to Pfizer's reaction, (or Pfizer's competition) when we post good NASH numbers. I predict we will see ambulance chaser's again. Our only way out of this IMO is a buyout or partner from BP. Every other entry on the playing field gets crushed by the FDA.
allows their competing drugs to flourish while others die" is exactly right.
NVAX suffered the exact same fake law suits we did, same firms, etc. Ours have now gone away because we are no longer a threat.
Will be interesting to Pfizer's reaction, (or Pfizer's competition) when we post good NASH numbers. I predict we will see ambulance chaser's again. Our only way out of this IMO is a buyout or partner from BP. Every other entry on the playing field gets crushed by the FDA.
(4)
(0)
